Industries > Pharma > Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027

North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing

PUBLISHED: 18 July 2017
PAGES: 311
PRODUCT CODE: PHA0214

Clear
WOOCS 2.2.1

The global pharmaceutical contract manufacturing market was valued at $76.6bn in 2016 and is expected to grow at a CAGR of 6.6% in the first half of the forecast period. Between 2011 and 2016, the top 5 emerging market CMOs grew at a CAGR of 13.6%, whereas the leading developed market CMOs grew at a CAGR of 1.7% over the same period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 311-page report you will receive 184 tables and 111 figures – all unavailable elsewhere.

The 311-page report provides clear detailed insight into the pharmaceutical CMOs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical Contract Manufacturing Market forecast from 2017-2027:
• API Manufacturing
• FDF Manufacturing
• Other Services

Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027

• This report profiles 30 leading CMOs in North America, Europe, Japan, China and India:
• Catalent
• Patheon
• Baxter
• AbbVie
• Pfizer
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Aenova
• Famar
• Vetter
• Almac
• Delpharm
• Siegfried
• Corden
• Recipharm
• Aesica
• Nipro
• Daito
• Teva API
• Esteve Quimica
• Euticals
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy’s Laboratories

• The content of each profile differs, depending on the organisation. In general, a profile gives the following information:

• Overview of the company’s contract manufacturing services and operations

• Analysis of recent financial performance – annual revenue for CMO services, including some data on operating profit and margins

• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations

SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2016 onwards

Forecasting of pharmaceutical manufacturing revenue to 2027, as well as projected operating profit and margin for some companies.

Visiongain’s study is intended for anyone requiring commercial analyses for the top 30 pharmaceutical CMOs market. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027: North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories